Physician profile
Thomas J Gilbert
NPI 1497706998
$1,007.59
in general payments reported to CMS, 2019-2025
14 companies · $287 in 2025
The $287 reported for 2025 was more than what 88% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $33.03 · 2021: $129 · 2022: $261 · 2023: $105 · 2024: $59.34 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $450.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $254.10 | 2020-2025 | Collagenase Santyl, Renasys Go V2 Home, Pico 7 |
| Organogenesis INC. | $207.93 | 2019-2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $164.21 | 2022-2025 | Nuzyra |
| Tactile Systems Technology INC | $65.33 | 2022-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Kerecis Limited | $61.08 | 2019-2022 | |
| Molecular Biologicals, INC | $56.71 | 2021 | |
| Hartmann USA, INC. | $48.64 | 2025 | Zetuvit Plus 10x10 P10 |
| Genentech USA, INC. | $32.43 | 2020-2021 | |
| Solventum Corporation | $23.85 | 2025 | Activ.A.C., Promogran Prisma |
| Triad Life Sciences INC. | $23.01 | 2022 | |
| Kci USA, INC. | $19.71 | 2023 | Promogran Prisma, Activ.A.C., V.A.C. Dermatac |
| Reprise Biomedical, INC. | $19.03 | 2025 | Miro3d |
| Mimedx Group, INC. | $16.97 | 2025 | |
| Cashflow Solutions, LLC | $14.59 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.